AdaptHealth Corp. (NASDAQ:AHCO) Shares Sold by Fiduciary Alliance LLC

Fiduciary Alliance LLC lowered its holdings in AdaptHealth Corp. (NASDAQ:AHCO) by 62.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,601 shares of the company’s stock after selling 26,000 shares during the period. Fiduciary Alliance LLC’s holdings in AdaptHealth were worth $154,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of AdaptHealth by 4.3% in the 3rd quarter. Vanguard Group Inc. now owns 8,656,553 shares of the company’s stock valued at $78,775,000 after purchasing an additional 355,005 shares during the period. Raymond James & Associates boosted its holdings in shares of AdaptHealth by 42.9% in the fourth quarter. Raymond James & Associates now owns 15,785 shares of the company’s stock worth $115,000 after buying an additional 4,740 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of AdaptHealth by 30.9% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 43,065 shares of the company’s stock worth $314,000 after buying an additional 10,162 shares during the period. Louisiana State Employees Retirement System purchased a new position in shares of AdaptHealth in the fourth quarter worth approximately $298,000. Finally, Strs Ohio raised its holdings in shares of AdaptHealth by 19.2% during the fourth quarter. Strs Ohio now owns 79,400 shares of the company’s stock valued at $578,000 after acquiring an additional 12,800 shares during the period. 82.67% of the stock is owned by institutional investors and hedge funds.

AdaptHealth Stock Performance

AHCO traded up $0.42 on Wednesday, hitting $9.08. The company had a trading volume of 2,385,726 shares, compared to its average volume of 1,072,693. AdaptHealth Corp. has a 1-year low of $6.37 and a 1-year high of $15.37. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.33 and a quick ratio of 1.11. The company’s fifty day moving average price is $10.55 and its 200 day moving average price is $9.81. The stock has a market cap of $1.21 billion, a price-to-earnings ratio of -1.72, a price-to-earnings-growth ratio of 0.76 and a beta of 1.10.

AdaptHealth (NASDAQ:AHCO) last announced its earnings results on Tuesday, August 6th. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.06). AdaptHealth had a negative net margin of 21.45% and a positive return on equity of 8.47%. The business had revenue of $805.98 million for the quarter, compared to the consensus estimate of $802.62 million. During the same quarter in the previous year, the company earned $0.16 EPS. AdaptHealth’s revenue for the quarter was up 1.6% compared to the same quarter last year. Equities analysts predict that AdaptHealth Corp. will post 0.82 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Truist Financial reissued a “buy” rating and set a $13.00 price target on shares of AdaptHealth in a research report on Wednesday, May 15th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, AdaptHealth currently has an average rating of “Hold” and a consensus target price of $10.70.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.